home
journals
ADHD in practice
British Journal of Renal Medicine
British Journal of Sexual Medicine
Clinical issues in HIV
Dermatology in practice
European Journal of Palliative Care
Managing pain in practice
Myeloid & Lymphoid disorders in practice
Ophthalmology in practice
Respiratory disease in practice
Rheumatology in practice
Thrombus
Vaccines in practice
Viral hepatitis in practice
editorial boards
ADHD in practice
British Journal of Renal Medicine
British Journal of Sexual Medicine
Dermatology in practice
European Journal of Palliative Care
Managing pain in practice
Myeloid & Lymphoid disorders in practice
Ophthalmology in practice
Respiratory disease in practice
Rheumatology in practice
Thrombus
Vaccines in practice
Viral hepatitis in practice
what is …? series
login
Thrombus - 2000
Winter 2000, Volume 4 Number 4
Autumn 2000, Volume 4 Number 3
Summer 2000, Volume 4 Number 2
Spring 2000, Volume 4 Number 1
Treatment of atrial fibrillation in the elderly
Dr Will Lester
pp 1-4
The role of anticoagulation in primary and secondary prevention of ischaemic stroke due to atrial fibrillation (AF) is well established. Analysis of pooled data from five randomised controlled trials of primary prevention that began in the 1980s, demonstrated a 68% risk reduction for patients treated with warfarin, with virtually no increase in the frequency of major bleeding. Evidence for the efficacy of warfarin in AF has continued to accumulate, with similar benefits evident in secondary prevention. The superiority of adjusted dose warfarin over low-intensity fixed-dose warfarin and aspirin has also become clear.
Comment: What’s the problem with prothrombin?
Peter Rose
pp 2-2
This issue covers topics as diverse as the ever-increasing problems of atrial fibrillation in the elderly, to the rare but often catastrophic problems seen with cerebral venous thrombosis (CVT). CVT is seldom seen in routine clinical practice and rarely discussed outside the world of neurology. An encounter, however, with a case of cavernous sinus thrombosis in a teenager, secondary to staphylococcal infection of the face, left me determined never to be overconcerned about matters related to one’s own complexion. It is reassuring to read in this edition that cases secondary to infection are now declining with the exception of immunocompromised patients.
Interaction between tramadol and warfarin
Andrew J McGuire and David S Binnie
pp 5-6
In this article, we report on an apparent drug interaction between warfarin and tramadol (Zydol), which led to an increase in the INR of a patient in our care. The apparent interaction came to light after the 82-year-old female patient presented with a short history of pain in her right buttock, groin and thigh in December 1998. Specialist orthopaedic opinion indicated that this was referred pain from her right sacroiliac joint.
An anticoagulant outreach service – a viable alternative to hospitalisation
Carole Connor
pp 7-8
In just over two years, the anticoagulant nursing service at Birmingham Heartlands and Solihull NHS Trust has safely and appropriately managed over 1,000 patients through a hospital outreach service at home instead of in acute hospital beds.
Cerebral venous thrombosis
Damian Wren
pp 9-11
Cerebral venous thrombosis (CVT) was first recognised in the early 19th century. The first report is attributed to Ribes by Bousser, with a case in the puerperium described by Abercrombie in 1828. Since then there have been many reports and series published. Most were initially from postmortems. These led to the classic description of the disease – still given in some text books – of a severe and often fatal neurological disease, characterised clinically by headache, papilloedema, seizures, focal neurological deficits and coma, and pathologically by haemorrhagic venous infarction of the brain. This resulted in the view that anticoagulation would be contraindicated.
This site uses cookies in order to function properly and to allow us to improve our service. By using this site you consent to the use of cookies as set out in our
privacy policy